Sign In
Buy CLPBY
$5.93
+0.0245 (+0.415%)
At Close: Jun 03, 2026
Coloplast A/S (CLPBF) Q3 2024 Earnings Call Transcript
02:40pm, Tuesday, 20'th Aug 2024
Coloplast A/S (OTCPK:CLPBF) Q3 2024 Earnings Conference Call August 20, 2024 5:00 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Execu
Coloplast A/S (CLPBF) Q2 2023/2024 Earnings Call Transcript
02:38pm, Friday, 10'th May 2024
Coloplast A/S (OTCPK:CLPBF) Q2 2023/2024 Earnings Conference Call May 7, 2024 3:00 AM ET Company Participants Kristian Villumsen - President and CEO Anders Lonning-Skovgaard - EVP and CFO Conference C
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
08:43am, Friday, 08'th Mar 2024
Please see enclosed pdf. Attachment 08032024_trading_in_shares_LRA
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
08:50am, Wednesday, 06'th Mar 2024
Please see enclosed pdf. Attachment 06032024_trading_in_shares_KVI
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
08:48am, Friday, 01'st Mar 2024
Please see enclosed pdf. Attachment 01032024_trading_in_shares_ARA
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
09:57am, Wednesday, 28'th Feb 2024
Please see enclosed pdf. Attachment 28022024_trading_in_shares_GL
Coloplast A/S - Allocation of Share Options
10:18am, Friday, 09'th Feb 2024
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactio
Coloplast Finance B.V. - Interim Financial Report, Q1 2023/24
07:04am, Friday, 09'th Feb 2024
Q1 2023/24 Interim financial results, Q1 2023/24 1 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported revenue in DKK grew 8% w
Coloplast A/S (CLPBF) Q4 2023 Earnings Call Transcript
09:45pm, Sunday, 12'th Nov 2023
Coloplast A/S (OTCPK:CLPBF) Q4 2023 Earnings Conference Call November 9, 2023 5:00 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Chie
Coloplast completes the acquisition of Kerecis
09:28am, Thursday, 31'st Aug 2023
Coloplast has completed the acquisition of Kerecis, announced on July 7, 2023, after receiving approval from all relevant authorities and reaching a shareholder acceptance level of 100%
Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of offering of 12.2 million new B shares
08:03pm, Tuesday, 29'th Aug 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMIT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMIT
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
02:45pm, Friday, 18'th Aug 2023
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
Coloplast A/S (CLPBF) Q3 2023 Earnings Call Transcript
02:20pm, Thursday, 17'th Aug 2023
Coloplast A/S (OTCPK:CLPBF) Q3 2023 Earnings Call Transcript August 17, 2023 4:30 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Chief
Coloplast Finance B.V. - Announcement no.
07:10am, Thursday, 17'th Aug 2023
9M 2022/23 Interim financial results, 9M 2022/23 1 October 2022 - 30 June 2023 Coloplast delivered Q3 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK grew 4% to 6,108 million Organ
